نتایج جستجو برای: thalidomide

تعداد نتایج: 3195  

2000
Stephen J. Oliver Gilla Kaplan

Scleroderma (SSc) is a fibrosing connective tissue disease that is poorly responsive to any treatment, including immune suppression. SSc shares many characteristics with chronic graft-versus-host disease (GVHD). Because the immunomodulatory drug thalidomide has proven beneficial in chronic GVHD, we studied the immune response and clinical effects of thalidomide in SSc patients. We treated 11 SS...

Journal: :Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 1997
A L Moreira J Wang E N Sarno G Kaplan

Thalidomide has been shown to selectively inhibit TNF-alpha production in vitro by lipopolysaccharide (LPS)-stimulated monocytes. TNF-alpha has been shown to play a pivotal role in the pathophysiology of endotoxic shock. Using a mouse model of LPS-induced shock, we investigated the effects of thalidomide on the production of TNF-alpha and other cytokines and on animal survival. After injection ...

Journal: :Blood 2012
Gareth J Morgan Walter M Gregory Faith E Davies Sue E Bell Alexander J Szubert Julia M Brown Nuria N Coy Gordon Cook Nigel H Russell Claudius Rudin Huw Roddie Mark T Drayson Roger G Owen Fiona M Ross Graham H Jackson J Anthony Child

Thalidomide maintenance has the potential to modulate residual multiple myeloma (MM) after an initial response. This trial compared the effect of thalidomide maintenance and no maintenance on progression-free survival (PFS) and overall survival (OS) in MM patients. After intensive or nonintensive induction therapy, 820 newly diagnosed MM patients were randomized to open-label thalidomide mainte...

Journal: :The Journal of infectious diseases 2000
N P Juffermans A Verbon D P Olszyna S J van Deventer P Speelman T van Der Poll

Concurrent infection in patients with human immunodeficiency virus (HIV) infection increases the expression of HIV coreceptors CXCR4 and CCR5. Thalidomide has beneficial effects in a number of HIV-associated diseases. The effect of thalidomide on CXCR4 and CCR5 expression on CD4+ T cells was determined. Thalidomide produced a dose-dependent inhibition of lipopolysaccharide (LPS)-induced up-regu...

Journal: :Diabetes care 2000
N Iqbal M Zayed G Boden

OBJECTIVE To investigate the effect of thalidomide on glucose turnover (glucose production and uptake), on intracellular pathways of glucose utilization (glycogen synthesis [GS], glycolysis [GLS], carbohydrate oxidation, and nonoxidative GLS), and on free fatty acid (FFA) turnover (lipolysis, FFA oxidation, and FFA reesterification). RESEARCH DESIGN AND METHODS A total of 6 patients with type...

2017
Bruno K.L Duarte Sílvia M. de Souza Carolina Costa-Lima Samuel S. Medina Margareth C. Ozelo

Angiodysplasia is a frequent cause of persistent gastrointestinal (GI) hemorrhage in elderly patients. Although GI bleeding isn't the most common manifestation in patients with bleeding disorders, when present, it represents a challenging complication. We describe a 62-year-old patient with Glanzmann's thrombasthenia, who used thalidomide for severe and recurrent GI bleeding. For 6 months, the ...

2005
Hassane Izzedine Gilbert Deray

mechanism behind this apparent thalidomide-induced hyperkalaemia remains unclear. Therefore, the authors recommend caution when thalidomide is used in patients with moderate to severe renal failure (serum creatinine >300mmol/l) or in patients on dialysis. To go a step further, we think that thalidomide should in all cases be started at a dosage that should not exceed 100mg/day. It is also impor...

Journal: :Blood 2004
Hannes Kaufmann Markus Raderer Stefan Wöhrer Andreas Püspök Alexander Bankier Christoph Zielinski Andreas Chott Johannes Drach

We evaluated a treatment strategy targeting both lymphoma cells (by rituximab) and the microenvironment (by thalidomide) in 16 patients with relapsed/refractory mantle cell lymphoma (MCL). Rituximab was administered at 375 mg/m(2) for 4 weekly doses concomitantly with thalidomide (200 mg daily, with a dose increment to 400 mg on day 15), which was continued as maintenance therapy until progress...

Journal: :The Journal of dermatology 2007
Cheng-Che E Lan Chi-Ling Lin Ching-Shuang Wu Chee-Yin Chai Wan-Tzu Chen Gwo-Shing Chen

Prurigo nodularis is an intensely pruritic dermatosis characterized by lichenified and excoriated papules and nodules. The course of prurigo nodularis is often chronic, and some patients respond very poorly to the standard therapeutic modalities. Because the pathogenesis of this disease remains obscure, the treatment of prurigo nodularis can be disappointing and frustrating for both the patient...

Journal: :Blood 1995
P M Parker N Chao A Nademanee M R O'Donnell G M Schmidt D S Snyder A S Stein E P Smith A Molina D E Stepan A Kashyap I Planas R Spielberger G Somlo K Margolin K Zwingenberger K Wilsman R S Negrin G D Long J C Niland K G Blume S J Forman

Thalidomide has been reported to be an effective agent for treatment of chronic graft-versus-host disease (CGVHD). To determine the efficacy of this agent in patients with refractory CGVHD a total of 80 patients who failed to respond to prednisone (PSE) or PSE and cyclosporine (CSA) were treated with thalidomide. Sixteen patients (20%) had a sustained response, 9 with a complete remission and 7...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید